Phase I study of immunotherapy of malignant melanoma by direct gene transfer.
Hersh
E M
EM
Hematology/Oncology Arizona Cancer Center Tucson 85724.
Akporiaye
E
E
Harris
D
D
Stopeck
A T
AT
Unger
E C
EC
Warneke
J A
JA
Kradjian
S A
SA
D000328:Adult; D000917:Antibody Formation; D002985:Clinical Protocols; D004274:DNA, Recombinant / Q000008:administration & dosage*; D005260:Female; D018014:Gene Transfer Techniques; D005822:Genetic Vectors; D015793:HLA-B7 Antigen / Q000235:genetics / Q000276:immunology / Q000627:therapeutic use*; D006801:Humans; D007111:Immunity, Cellular; D007167:Immunotherapy / Q000379:methods*; D007258:Informed Consent; D015552:Injections, Intralesional; D008297:Male; D008545:Melanoma / Q000556:secondary* / Q000628:therapy*; D010957:Plasmids; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology
D004274:DNA, Recombinant; D015793:HLA-B7 Antigen